# Task V02: Immunogenicity and Efficacy Testing of Medical Countermeasures (Vaccines and Other Biologics) against BSL-4 Pathogens in Non-Human Primates

> **NIH NIH N01** · BATTELLE CENTERS/PUB HLTH RES & EVALUATN · 2022 · $134,146

## Abstract

The Evaluation and Testing Services (ETS) for Vaccines and Other Biologics for Infectious Diseases contract provides a variety of product development services from early feasibility studies through activities required for the submission of Biologic License Application (BLA) and/or Investigational New Drug (IND) applications. These services will facilitate the development and introduction of new vaccine candidates and biologics (regulated by CBER) against a wide array of infectious diseases.

## Key facts

- **NIH application ID:** 10636609
- **Project number:** 272201800013I-P00006-759301900131-1
- **Recipient organization:** BATTELLE CENTERS/PUB HLTH RES & EVALUATN
- **Principal Investigator:** THOMAS RUDGE
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $134,146
- **Award type:** —
- **Project period:** 2019-08-01 → 2025-12-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10636609

## Citation

> US National Institutes of Health, RePORTER application 10636609, Task V02: Immunogenicity and Efficacy Testing of Medical Countermeasures (Vaccines and Other Biologics) against BSL-4 Pathogens in Non-Human Primates (272201800013I-P00006-759301900131-1). Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/grant/nih/10636609. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*